About this Webinar: This session will provide participants with an overview of what is involved in getting a new cancer treatment reviewed and approved in Canada. The webinar will feature representatives from 3Sixty Public Affairs, who will detail the key steps required to provide patient access to a new treatment option. The journey begins with a Health Canada review of safety, efficacy and quality. That is followed by comparative cost and effectiveness evaluations and the establishmentof a place in therapy by health technology assessment (HTA) agencies. After the HTA recommendations are issued, then the national pricing negotiation process takes place, followed by reimbursement decision-making at the jurisdictional level. During all that, new products also must pass through a national price review. Patients and stakeholders have some opportunities to provide input at various points in the process. All that and more will be covered during the presentation. Afterward, the presenters will lead an interactive question and answer session that will permit audience members to explore these processes further.